Completed NA INTERVENTIONAL 2-arm NCT04625088

Identification of Biometric Marker(s) Capable of Detecting Early Prediabetes: Clinical Trial 1

Identification of Biometric Marker(s) Capable of Detecting Early Prediabetes: Clinical Trial 1: Antagonism of Hepatic Muscarinic Receptors Attenuates the Postprandial Actions of Hepatic Insulin Sensitizing Substance (HISS)

Sponsor: SciMar Ltd.

Conditions Healthy

Interventions Atropine + Standardized liquid test meal Standardized liquid test meal

Updated 7 times since 2020 Last updated: Feb 2, 2022 Started: Mar 1, 2021 Primary completion: Aug 6, 2021 Completion: Aug 6, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Healthy and is currently completed. SciMar Ltd. leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Apr 2021 — Mar 2022 [monthly]

Recruiting NA
Mar 2021 — Apr 2021 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Jan 2021 — Mar 2021 [monthly]

Recruiting NA
Dec 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

SciMar Ltd.
Source Nutraceutical, Inc.

Data source: SciMar Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Winnipeg, Canada